果酱视频

The Melatonin market in the United States concluded June 2026 on a stable footing despite registering a modest monthly decline. Melatonin prices remained unchanged during the final week of June, reflecting balanced supply-demand fundamentals after a brief softening earlier in the month. Early June witnessed stable trading conditions supported by consistent procurement from nutraceutical and over-the-counter supplement manufacturers, while mid-month buying activity slowed slightly, resulting in limited downward pressure. However, demand recovered toward the end of June, allowing the Melatonin market to regain equilibrium and maintain stable weekly pricing.

Demand for Melatonin followed a mixed pattern throughout June. Routine replenishment from dietary supplement manufacturers supported the market during the first half of the month, but procurement activity weakened briefly in mid-June as buyers adopted a cautious purchasing strategy amid sufficient inventories. By late June, inquiries improved, helping stabilize Melatonin prices. Despite this recovery, the broader market continued to reflect the impact of an ongoing correction, with the 12-week moving average remaining on a downward trajectory. This indicates that although short-term demand has steadied, Melatonin continues to experience mild bearish momentum compared to previous months.

Supply-side conditions remained favorable throughout June. Stable feedstock costs ensured that Melatonin production economics remained unchanged, preventing significant cost-driven price fluctuations. Manufacturers maintained steady operating rates while inventories remained sufficient to meet downstream requirements. No major production outages, maintenance shutdowns, or logistical disruptions affected availability during the month. Balanced inventory levels and uninterrupted production allowed the Melatonin supply chain to function smoothly, contributing to the calm market environment observed in late June.

Weekly price movements highlighted the market's stability. Early June recorded largely unchanged Melatonin prices before a modest decline of approximately 0.4% emerged during the middle of the month. This minor correction aligned with the broader multi-week bearish trend rather than reflecting any major deterioration in market fundamentals. By the final week of June, Melatonin prices stabilized once again as balanced purchasing and adequate supply restored market equilibrium. Overall, the monthly trend pointed to a controlled correction rather than a significant downturn.

Looking ahead, analysts expect the Melatonin market to remain rangebound during the coming weeks. Stable production costs, balanced inventories, and consistent downstream demand are expected to limit major price volatility. Unless stronger seasonal demand or unexpected feedstock cost increases emerge, Melatonin prices are likely to trade within a narrow range. Current market indicators suggest that downside risks remain limited, while any meaningful upward movement will depend on stronger purchasing activity from nutraceutical manufacturers and broader improvements in consumer demand.